Evidence map›Paper›PMID 39045384›Full record

ArticleIJID regions2024

Prospective cohort study of patient demographics, viral agents, seasonality, and outcomes of influenza-like illness in Mexico in the late H1N1-pandemic and post-pandemic years (2010-2014).

Arturo Galindo-Fraga, Paola Del Carmen Guerra-de-Blas, Ana A Ortiz-Hernández, Kevin Rubenstein, Ana M Ortega-Villa, Alejandra Ramírez-Venegas, Rafael Valdez-Vázquez, Sarbelio Moreno-Espinosa, Beatriz Llamosas-Gallardo, Santiago Pérez-Patrigeon and 8 more

Abstract read
In one paragraph

Article in IJID regions, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Arturo Galindo-FragaSubdirección de Epidemiología Hospitalaria, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Paola Del Carmen Guerra-de-BlasThe Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico.
Ana A Ortiz-HernándezDivisión de Desarrollo y Enlace Interinstitucional, Instituto Nacional de Pediatría, Mexico City, Mexico.
Kevin RubensteinClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Ana M Ortega-VillaNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Alejandra Ramírez-VenegasDepartamento de Investigación en Tabaquismo y EPOC, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Rafael Valdez-VázquezDepartamento de Infectología, Hospital General Dr. Manuel Gea González, Mexico City, Mexico.
Sarbelio Moreno-EspinosaDepartamento de Infectología, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
Beatriz Llamosas-GallardoDivisión de Desarrollo y Enlace Interinstitucional, Instituto Nacional de Pediatría, Mexico City, Mexico.
Santiago Pérez-PatrigeonDivision of Infectious Diseases, Queen's University, Kingston, Ontario, Canada.
Daniel E NoyolaDepartamento de Microbiología y Centro de Investigación en Ciencias de la Salud y Biomedicina, Facultad de Medicina, Universidad Autónoma de San Luís Potosí, San Luis Potosí, Mexico.
Martín Magaña-AquinoHospital Regional Dr. Ignacio Morones Prieto, San Luis Potosí, Mexico.
Ana Vilardell-DávilaThe Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico.
M Lourdes GuerreroDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
John H PowersClinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
John BeigelNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Guillermo M Ruiz-PalaciosDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Mexican Emerging Infectious Disease Clinical Research Network

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
NCI NIH HHS 75N91019D00024
6 · The paper itself

Abstract

Objectives: Influenza-like illness (ILI) caused by respiratory viruses results in various respiratory clinical manifestations. The ILI002 prospective observational cohort study aimed to describe viral agents, seasonality, and outcomes of patients with ILI during four seasons in the influenza H1N1-pandemic and post-pandemic years (2010-2014). Methods: Patients from six Mexican hospitals were enrolled from April 2010 to March 2014. Clinical data and nasopharyngeal swabs were obtained and tested for viral respiratory pathogens by real-time reverse-transcription polymerase chain reaction. Results: Of the 5662 enrolled participants, 64.9% were adults and 35.1% were children. Among the 5629 participants with single-pathogen detection, rhinovirus (20.2%), influenza virus (11.2%), respiratory syncytial virus (RSV) (7.2%), and coronavirus (6.8%) were the most frequent pathogens. Co-infection occurred in 14.5% of cases; 49.3% of participants required hospitalization, particularly in RSV cases (42.9% adults, 89.6% children). The mortality rate was 2.8% higher among older adult participants and those with comorbidities. Influenza H1N1 had the highest mortality rate, yet almost half of the deceased had no pathogen. Rhinovirus persisted year-round, while influenza, coronavirus, and RSV peaked during cooler months. Conclusions: Analyses showed that some viruses causing ILI may lead to severe disease and hospitalization irrespective of comorbidities. These findings may help in decision-making about public health policies on prevention measures, vaccination, treatment, and administration of health care.

Indexed as

Clinical characteristicsInfluenza-like illnessRespiratory virusesSeasonality

Identifiers

PMID39045384
PMCPMC11265585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.